GARDELLINI, ANGELO
GARDELLINI, ANGELO
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL) : results of a prospective, single-arm multicentre study
2009 A. Cortelezzi, M.C. Pasquini, A. Gardellini, U. Gianelli, A. Bossi, G. Reda, B. Sarina, P. Musto, W. Barcellini, A. Neri, G. Lambertenghi Deliliers
Low dose dasatinib in refractory imatinib mesylate chronic myeloid leukemia : case report
2007 F. Radaelli, G. Reda, F. Ripamonti, A. Gardellini, C. Vener, G. Lambertenghi Deliliers
Role of dasatinib in PH '-positive acute lymphoblastic leukemia (ALL) after imatinib-based therapy failure : a case report
2007 A. Cortelezzi, M.C. Pasquini, F. Radaelli, G. Reda, F. Ripamonti, A. Gardellini, D. Intini, O. Spinelli, G. Lambertenghi Deliliers
Plasma homocysteine and oxydative stress in polycythemia vera and essential thrombocythemia. Effect of folic acid supplementation
2005 M. Pugliano, M.L. Biondi, C. Vanelli, A. Gardellini, L. Battaglioli, M. Erario, A. La Torre, O. Turri, C. Maioli, G. Gerli
SDF1-3'A gene polymorphism : risk factor for thrombotic events in Philadelphia-negative chronic myeloproliferative disorders
2005 C. Vanelli, M.L. Biondi, O. Turri, A. La Torre, A. Gardellini, M. Pugliano, L. Battaglioli, M. Erario, G. Gerli
Endothelial nitric oxide synthase gene polymorphisms (G894T and T786C) in essential throbocythemia
2005 A. Gardellini, M.L. Biondi, O. Turri, M. Pugliano, C. Vanelli, L. Battaglioli, M. Erario, A. La Torre, G. Gerli
SDF1-3'A gene polymorphism is associated with chronic myeloproliferative disease and thrombotic events
2005 G. Gerli, C. Vanelli, O. Turri, M. Erario, A. Gardellini, M. Pugliano, M.L. Biondi